Recall · openFDA Food Enforcement

Boswellia Herbal Supplement, 1:5 Alcohol Double Extract…: FDA Recall H-0343-2026

Agency action: Nov 20, 2025Record ID: H-0343-2026
View official source ↗

What happened

Original notice title

Boswellia Herbal Supplement, 1:5 Alcohol Double Extract, Extracted from Frankincense with powerful anti-inflammatory properties, useful for pain & inflammation, recall H-0343-2026

From the archived source record

Unapproved drug claims on product labeling and product misbranded due to no Supplement Facts label

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Ongoing
FDA recall classification
Class II
Recall initiated by
Voluntary: Firm initiated
Report date
Dec 31, 2025
Source checked
Jul 16, 2026
Record revision
31faadadb8dc

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Boswellia Herbal Supplement, 1:5 Alcohol Double Extract, Extracted from Frankincense with powerful anti-inflammatory properties, useful for pain & inflammation; packaged in a 2 oz. glass dropper bottle, UPC 284260392420
Company
A New Life Herbs, LLC
Lot / identifier
T848B EXP 11/30 T836B EXP 10/30 T808B EXP 9/30 T771B EXP 7/30 T723B EXP 3/30 T696B EXP 1/29 T655B EXP 10/29 T594B EXP 4/29 T536B EXP 10/28
Market / distribution
AL, AZ, CA, GA, IL, IN, MN, MO, MS, NC, NY, TN